Zhejiang Jiuzhou Pharmaceutical Co., Ltd (SHA:603456)

China flag China · Delayed Price · Currency is CNY
16.63
-0.19 (-1.13%)
At close: Mar 9, 2026
21.65%
Market Cap 14.66B
Revenue (ttm) 5.36B
Net Income (ttm) 722.87M
Shares Out 881.71M
EPS (ttm) 0.82
PE Ratio 20.31
Forward PE 13.41
Dividend 0.40 (2.38%)
Ex-Dividend Date Sep 8, 2025
Volume 10,675,780
Average Volume 11,203,529
Open 16.65
Previous Close 16.82
Day's Range 16.41 - 16.71
52-Week Range 11.90 - 22.25
Beta 0.32
RSI 33.49
Earnings Date Apr 24, 2026

About SHA:603456

Zhejiang Jiuzhou Pharmaceutical Co., Ltd operates as contract development and manufacturing organization (CDMO) company in China and internationally. The company offers small molecule, drug product, and peptide CDMO services. It also involved in business related to supporting the development of new drugs and pharmaceuticals. It serves global pharmaceutical companies, biotechnology companies, and scientific research institutions. Zhejiang Jiuzhou Pharmaceutical Co., Ltd was founded in 1973 and is headquartered in Taizhou, China. [Read more]

Sector Healthcare
Founded 1973
Employees 5,001
Stock Exchange Shanghai Stock Exchange
Ticker Symbol 603456
Full Company Profile

Financial Performance

In 2024, SHA:603456's revenue was 5.16 billion, a decrease of -6.57% compared to the previous year's 5.52 billion. Earnings were 606.10 million, a decrease of -41.34%.

Financial Statements

News

There is no news available yet.